DaVita Inc.
Financials
Valuation Metrics
DaVita Inc.'s Market Cap is $11.91B. At end of 2025 it was $9.78B. Ranked #800 of 3,116 in US market (top 26%), #551 of 1,644 on NYSE (top 34%), #54 of 203 in Health Care Equipment & Services (top 27%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $11.91B | US#800/3,116 Sec#54/203 |
| Revenue | $14.17B | US#441/3,116 Sec#30/203 |
| Net Income | $920M | US#613/3,116 Sec#35/203 |
| Total Assets | $17.82B | US#672/3,116 Sec#31/203 |
| Net Assets | $-591M | US#3,026/3,116 Sec#201/203 |
| Employees | 78,000 | US#158/3,116 Sec#11/203 |
| Value | ||
| P/E | 12.95x | US#724/3,116 Sec#10/203 |
| PEG | 0.67x | US#1,226/3,116 Sec#68/203 |
| P/S | 0.84x | US#638/3,116 Sec#42/203 |
| EV/EBITDA | 8.86x | US#547/3,116 Sec#15/203 |
| FCF Yield | 10.86% | US#363/3,116 Sec#10/203 |
| Profitability | ||
| ROA | 5.16% | US#1,082/3,116 Sec#70/203 |
| Op. Margin | 14.85% | US#1,190/3,116 Sec#44/203 |
| Revenue Growth | 6.38% | US#1,621/3,116 Sec#118/203 |
| Earnings Growth | 19.19% | US#1,256/3,116 Sec#70/203 |
| Financial Health | ||
| Total Debt | $13.39B | US#391/3,116 Sec#21/203 |
| FCF | $1.29B | US#424/3,116 Sec#28/203 |
| Cash | $496M | US#898/3,116 Sec#49/203 |
| Current Ratio | 1.41x | US#1,690/3,116 Sec#151/203 |
| Net Debt/EBITDA | 4.61x | US#1,775/3,116 Sec#115/203 |
| Dividend | ||
| Div. Yield | 1.26% | US#1,217/3,116 Sec#21/203 |
| Performance | ||
| 1Y Return | 55.94% | US#466/3,116 Sec#50/203 |
| 1M Return | 3.87% | US#693/3,116 Sec#67/203 |
| From 52W High | -25.01% | US#1,626/3,116 Sec#137/203 |
| 1Y MDD | -27.86% | US#1,153/3,116 Sec#50/203 |
| Trading | ||
| Volume | 735,613 shares | US#990/3,116 Sec#52/203 |
| Trading Value | $135M | US#321/3,116 Sec#25/203 |
| Per Share | ||
| EPS | $14.33 | US#187/3,116 Sec#15/203 |
| BPS | $-9.21 | US—/3,116 Sec—/203 |
Company Info
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.